Mapping local and long-distance resting connectivity markers of TMS-related inhibition reduction in schizophrenia.
Regional homogeneity (ReHo)
Resting fMRI
Schizophrenia
Short-interval intracortical inhibition (SICI)
Transcranial magnetic stimulation (TMS)
Journal
NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
10
2020
revised:
07
03
2021
accepted:
26
04
2021
pubmed:
16
5
2021
medline:
11
9
2021
entrez:
15
5
2021
Statut:
ppublish
Résumé
Short interval intracortical inhibition (SICI) is a biomarker for altered motor inhibition in schizophrenia, but the manner in which distant sites influence the inhibitory cortical-effector response remains elusive. Our study investigated local and long-distance resting state functional connectivity (rsFC) markers of SICI in a sample of N = 23 patients with schizophrenia and N = 29 controls. Local functional connectivity was quantified using regional homogeneity (ReHo) analysis and long-range connectivity was estimated using seed-based rsFC analysis. Direct and indirect effects of connectivity measures on SICI were modeled using mediation analysis. Higher SICI ratios (indicating reduced inhibition) in patients were associated with lower ReHo in the right insula. Follow-up rsFC analyses showed that higher SICI scores (indicating reduced inhibition) were associated with reduced connectivity between right insula and hubs of the corticospinal pathway: sensorimotor cortex and basal ganglia. Mediation analysis supported a model in which the direct effect of local insular connectivity strength on SICI is mediated by the interhemispheric connectivity between insula and left sensorimotor cortex. The broader clinical implications of these findings are discussed with emphasis on how these preliminary findings might inform novel interventions designed to restore or improve SICI in schizophrenia and deepen our understanding of motor inhibitory control and impact of abnormal signaling in motor-inhibitory pathways in schizophrenia.
Identifiants
pubmed: 33991855
pii: S2213-1582(21)00132-7
doi: 10.1016/j.nicl.2021.102688
pmc: PMC8135038
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102688Subventions
Organisme : NIBIB NIH HHS
ID : R21 EB001561
Pays : United States
Organisme : NIDA NIH HHS
ID : UG3 DA047685
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB015611
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC014085
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH111671
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH108148
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH067533
Pays : United States
Organisme : NIMH NIH HHS
ID : RF1 MH123163
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH103222
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH121246
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116948
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH073526
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112180
Pays : United States
Organisme : NIH HHS
ID : S10 OD023696
Pays : United States
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.